Modulation of in vivo cardiac hypertrophy with insulin-like growth factor-1 and angiotensin-converting enzyme inhibitor: Relationship between change in myosin isoform and progression of left ventricular dysfunction

Journal of the American College of Cardiology

Volumn 36, Issue 2, 2000, Pages 635-642

  Iwanaga, Yoshitaka ^a   Kihara, Yasuki ^a   Yoneda, Takeshi ^a   Aoyama, Takeshi ^a   Sasayama, Shigetake ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ISOPROTEIN; MESSENGER RNA; MYOSIN HEAVY CHAIN; RECOMBINANT SOMATOMEDIN C; TEMOCAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; HEART DILATATION; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART PERFORMANCE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HEMODYNAMICS; HYPERTENSION; LUNG CONGESTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RAT; RAT STRAIN; SURVIVAL TIME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CARDIOMEGALY; EVALUATION STUDIES; INSULIN-LIKE GROWTH FACTOR I; MALE; MYOCARDIUM; MYOSIN HEAVY CHAINS; RANDOM ALLOCATION; RATS; RATS, INBRED STRAINS; THIAZEPINES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033861574     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00769-5     Document Type: Article

References (46)

1. The cardiomyopathy of overload: An unnatural growth response in the hypertrophied heart
2. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
3. Long-term β-blockade in dilated cardiomyopathy: Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol
4. Acute and short-term effects of the nonpeptide endothelin-1 receptor antagonist bosentan in humans
5. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin
6. Growth hormone and the heart
7. Insulin-like growth factor-I enhances ventricular hypertrophy and function during the onset of experimental cardiac failure
8. Growth hormone improves cardiac performance in experimental heart failure
9. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy
10. Randomized, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
11. Lack of beneficial effects of growth hormone treatment in conscious dogs during development of heart failure
12. Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats
13. Neurohumoral factors during transition from left ventricular hypertrophy to failure in Dahl salt-sensitive rats
14. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats
15. Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion
16. Dahl salt-sensitive rats and human essential hypertension
17. Chronic angiotensin-converting enzyme inhibition and angiotensin-II type 1 receptor blockade: Effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis
18. Measurement of left ventricular wall thickness and mass by echocardiography
19. Radioimmunoassay for insulin-like growth factor I: Solutions to some potential problems and pitfalls
20. Determination of hydroxyproline
21. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links
22. Structure of rat atrial natriuretic factor precursor deduced from cDNA sequence
23. Complete nucleotide sequence of full length cDNA for rat alpha cardiac myosin heavy chain
24. 2+-dependent ATPase from rabbit muscle sarcoplasmic reticulum, deduced from its complementary DNA sequence
25. Clenbuterol induces hypertrophy of the latissimus dorsi muscle and heart in the rat with molecular and phenotypic changes
26. Mechanical properties of rat cardiac skinned fibers are altered by chronic growth hormone hypersecretion
27. 2+ handling and enhance cardiac performance
28. Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction
29. Deficient insulin-like growth factor-I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation
30. Angiotensin-II causes weight loss and decreases circulating insulin-like growth factor-I in rats through a pressor-independent mechanism
31. Insulin resistance and blood pressure in Dahl rats and in one-kidney, one-clip hypertensive rats
32. Tissue availability of insulin-like growth factor-I is inversely related to insulin resistance in essential hypertension: Effects of angiotensin-converting enzyme inhibition
33. Why does the myocardium fail? Insights from basic science
34. Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure
35. Increased myothermal economy of isometric force generation in compensated cardiac hypertrophy induced by pulmonary artery constriction in the rabbit
36. The economy of force development, myosin isoenzyme pattern and myofibrillar ATPase activity in normal and hyperthyroid rat myocardium
37. Effects of IGF-1 on cardiac growth and expression of mRNAs coding for cardiac proteins after induction of heart hypertrophy in the rat
38. Some growth factors stimulate cultured adult rabbit ventricular myocyte hypertrophy in the absence of mechanical loading
39. Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles
40. Myosin isozymes in normal and hypertrophied human ventricle myocardium
41. Distribution pattern of α and β myosin in normal and diseased human ventricular myocardium
42. Myosin heavy chain gene expression in human heart failure
43. Changes in gene expression in the intact human heart
44. Cross-bridge dynamics in human ventricular myocardium
45. Reduced cardiac myofibrillar Mg-ATPase activity without changes in myosin isoenzymes in patients with end-stage heart failure
46. Activated tissue reninangiotensin systems add to the progression of heart failure